This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Ilias Biologics Inc., Ilias Therapeutics, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Ramkumar Menon: Innovator in Exosome Research
Introduction
Ramkumar Menon is a notable inventor based in Galveston, Texas. He has made significant contributions to the field of biotechnology, particularly in the area of exosome research. His work focuses on developing innovative solutions for improving fetal health and addressing inflammatory conditions.
Latest Patents
Ramkumar Menon holds a patent for "Compositions containing exosome carrying NF-κB inhibitors and methods of using thereof." This invention relates to compositions that utilize extracellular vesicles, specifically exosomes, to enhance the lifespan and viability of fetuses and newborns. The patent also addresses methods for treating inflammation in the uterus and fetus, delaying preterm birth, and managing conditions associated with inflammation. The compositions include a nuclear factor kappa beta (NF-κB) inhibitor and a photo-specific binding protein.
Career Highlights
Throughout his career, Ramkumar Menon has worked with various organizations, including Ilias Therapeutics, Inc. and Ilias Biologics Inc. His experience in these companies has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Ramkumar has collaborated with notable colleagues, including Kyungsun Choi and Chulhee Choi. These partnerships have further enriched his research endeavors and have played a crucial role in the advancement of his inventions.
Conclusion
Ramkumar Menon is a pioneering inventor whose work in exosome research has the potential to transform fetal health care. His innovative patent and collaborations highlight his commitment to advancing medical science and improving outcomes for mothers and their children.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile